Morgan Stanley’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.2M | Sell |
2,481,104
-687,638
| -22% | -$3.12M | ﹤0.01% | 3408 |
|
|
2026
Q1 | $14.3M | Sell |
3,168,742
-439,047
| -12% | -$2.29M | ﹤0.01% | 3263 |
|
|
2025
Q4 | $22.2M | Sell |
3,607,789
-9,136
| -0.3% | -$66.2K | ﹤0.01% | 2843 |
|
|
2025
Q3 | $26.2M | Sell |
3,616,925
-937,155
| -21% | -$5.56M | ﹤0.01% | 2626 |
|
|
2025
Q2 | $24.2M | Buy |
4,554,080
+2,939,498
| +182% | +$17.4M | ﹤0.01% | 2607 |
|
|
2025
Q1 | $14.3M | Buy |
1,614,582
+329,465
| +26% | +$3.96M | ﹤0.01% | 3013 |
|
|
2024
Q4 | $17.6M | Buy |
1,285,117
+404,130
| +46% | +$7.46M | ﹤0.01% | 2886 |
|
|
2024
Q3 | $24.1M | Sell |
880,987
-491,650
| -36% | -$13.3M | ﹤0.01% | 2611 |
|
|
2024
Q2 | $33.6M | Sell |
1,372,637
-299,116
| -18% | -$6.56M | ﹤0.01% | 2136 |
|
|
2024
Q1 | $35.6M | Buy |
1,671,753
+835,846
| +100% | +$18M | ﹤0.01% | 2086 |
|
|
2023
Q4 | $16M | Buy |
835,907
+281,255
| +51% | +$4.87M | ﹤0.01% | 2905 |
|
|
2023
Q3 | $8.9M | Sell |
554,652
-91,974
| -14% | -$1.75M | ﹤0.01% | 3227 |
|
|
2023
Q2 | $15M | Buy |
646,626
+21,224
| +3% | +$463K | ﹤0.01% | 2775 |
|
|
2023
Q1 | $14.5M | Sell |
625,402
-271,479
| -30% | -$5.51M | ﹤0.01% | 2776 |
|
|
2022
Q4 | $13M | Buy |
896,881
+212,232
| +31% | +$3.95M | ﹤0.01% | 2801 |
|
|
2022
Q3 | $13.1M | Sell |
684,649
-33,259
| -5% | -$763K | ﹤0.01% | 2675 |
|
|
2022
Q2 | $13M | Buy |
717,908
+140,060
| +24% | +$2.91M | ﹤0.01% | 2775 |
|
|
2022
Q1 | $14.6M | Buy |
577,848
+120,611
| +26% | +$3.09M | ﹤0.01% | 2451 |
|
|
2021
Q4 | $12.6M | Sell |
457,237
-404,501
| -47% | -$11.7M | ﹤0.01% | 2677 |
|
|
2021
Q3 | $27.8M | Buy |
861,738
+7,574
| +0.9% | +$252K | ﹤0.01% | 1751 |
|
|
2021
Q2 | $26.1M | Buy |
854,164
+107,760
| +14% | +$3.11M | ﹤0.01% | 1877 |
|
|
2021
Q1 | $22.7M | Sell |
746,404
-1,477,464
| -66% | -$41.9M | ﹤0.01% | 1790 |
|
|
2020
Q4 | $44M | Buy |
2,223,868
+1,430,509
| +180% | +$23.1M | 0.01% | 1179 |
|
|
2020
Q3 | $10.3M | Sell |
793,359
-62,103
| -7% | -$786K | ﹤0.01% | 1997 |
|
|
2020
Q2 | $9.7M | Sell |
855,462
-275,784
| -24% | -$3.92M | ﹤0.01% | 1995 |
|
|
2020
Q1 | $16.2M | Sell |
1,131,246
-742,039
| -40% | -$15.7M | ﹤0.01% | 1431 |
|
|
2019
Q4 | $51M | Buy |
1,873,285
+1,138,223
| +155% | +$31.3M | 0.01% | 920 |
|
|
2019
Q3 | $21M | Buy |
735,062
+262,240
| +55% | +$7.64M | 0.01% | 1454 |
|
|
2019
Q2 | $13.1M | Buy |
472,822
+354,233
| +299% | +$10M | ﹤0.01% | 1871 |
|
|
2019
Q1 | $3.94M | Sell |
118,589
-505,669
| -81% | -$15.4M | ﹤0.01% | 2938 |
|
|
2018
Q4 | $18.1M | Sell |
624,258
-113,069
| -15% | -$4.07M | 0.01% | 1542 |
|
|
2018
Q3 | $33.9M | Buy |
737,327
+387,692
| +111% | +$17.2M | 0.01% | 1235 |
|
|
2018
Q2 | $13.1M | Sell |
349,635
-67,308
| -16% | -$2.27M | ﹤0.01% | 2074 |
|
|
2018
Q1 | $12.3M | Buy |
416,943
+1,921
| +0.5% | +$65K | ﹤0.01% | 2144 |
|
|
2017
Q4 | $14.3M | Buy |
415,022
+165,645
| +66% | +$5.59M | ﹤0.01% | 2029 |
|
|
2017
Q3 | $9.02M | Buy |
249,377
+53,597
| +27% | +$1.53M | ﹤0.01% | 2383 |
|
|
2017
Q2 | $5.06M | Sell |
195,780
-73,408
| -27% | -$1.56M | ﹤0.01% | 2827 |
|
|
2017
Q1 | $5.17M | Sell |
269,188
-833,566
| -76% | -$14.8M | ﹤0.01% | 2833 |
|
|
2016
Q4 | $18.4M | Sell |
1,102,754
-331,419
| -23% | -$6M | 0.01% | 1620 |
|
|
2016
Q3 | $29.5M | Buy |
1,434,173
+158,899
| +12% | +$4.03M | 0.01% | 1170 |
|
|
2016
Q2 | $39M | Buy |
1,275,274
+622,166
| +95% | +$21.6M | 0.01% | 944 |
|
|
2016
Q1 | $24.4M | Buy |
653,108
+38,699
| +6% | +$1.46M | 0.01% | 1196 |
|
|
2015
Q4 | $26.5M | Buy |
614,409
+481,702
| +363% | +$20.4M | 0.01% | 1201 |
|
|
2015
Q3 | $4.97M | Sell |
132,707
-71,602
| -35% | -$2.54M | ﹤0.01% | 2667 |
|
|
2015
Q2 | $6.95M | Buy |
204,309
+30,770
| +18% | +$1.05M | ﹤0.01% | 2488 |
|
|
2015
Q1 | $6.14M | Sell |
173,539
-150,111
| -46% | -$5.37M | ﹤0.01% | 2555 |
|
|
2014
Q4 | $11M | Sell |
323,650
-78,476
| -20% | -$2.78M | ﹤0.01% | 1973 |
|
|
2014
Q3 | $15.5M | Sell |
402,126
-134,759
| -25% | -$5.03M | 0.01% | 1637 |
|
|
2014
Q2 | $20.9M | Sell |
536,885
-204,482
| -28% | -$7.61M | 0.01% | 1406 |
|
|
2014
Q1 | $25.3M | Buy |
741,367
+3,160
| +0.4% | +$97.9K | 0.01% | 1184 |
|
|
2013
Q4 | $15.5M | Buy |
738,207
+197,729
| +37% | +$5M | 0.01% | 1566 |
|
|
2013
Q3 | $12.7M | Sell |
540,478
-74,152
| -12% | -$2.11M | 0.01% | 1576 |
|
|
2013
Q2 | $16.5M | Buy |
+614,630
| New | +$17.8M | 0.01% | 1301 |
|
Other funds holding MYGN
VPC
Morgan Stanley's MYGN Position: Q2 2026 in Review
Morgan Stanley reduced its Myriad Genetics (MYGN) stake by 22% in Q2 2026, selling an estimated $3.12M and leaving 2,481,104 shares worth $14.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3408.
Morgan Stanley first reported a position in MYGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $51M in Q4 2019. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Morgan Stanley held 2,481,104 shares of Myriad Genetics worth $14.2M as of Q2 2026.
- Morgan Stanley sold 687,638 Myriad Genetics shares in Q2 2026, an estimated $3.12M.
- Myriad Genetics made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3408 holding.
- Morgan Stanley first reported a position in Myriad Genetics in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Myriad Genetics position peaked at $51M in Q4 2019.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.